0001209191-15-032248.txt : 20150403
0001209191-15-032248.hdr.sgml : 20150403
20150403160913
ACCESSION NUMBER: 0001209191-15-032248
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150401
FILED AS OF DATE: 20150403
DATE AS OF CHANGE: 20150403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celladon Corp
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330971591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11988 EL CAMINO REAL
STREET 2: SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-366-4288
MAIL ADDRESS:
STREET 1: 11988 EL CAMINO REAL
STREET 2: SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TAKEYA RYAN K
CENTRAL INDEX KEY: 0001590702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 15751379
MAIL ADDRESS:
STREET 1: C/O CELLADON CORPORATION
STREET 2: 12760 HIGH BLUFF DRIVE, SUITE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-04-01
0
0001305253
Celladon Corp
CLDN
0001590702
TAKEYA RYAN K
11988 EL CAMINO REAL STE. 650
SAN DIEGO
CA
92130
0
1
0
0
VP, Manufacturing
Common Stock
2015-04-01
4
M
0
4444
1.12
A
5876
D
Common Stock
2015-04-01
4
S
0
4444
19.13
D
1432
D
Stock option (right to buy)
1.12
2015-04-01
4
M
0
4444
0.00
D
2013-01-27
2022-06-14
Common Stock
4444
139574
D
The amount includes shares purchased under Celladon Corporation's employee stock purchase plan prior to the reported transaction.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 15, 2014.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.84 to $19.36 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.
/s/ Rebecque J. Laba, Attorney-in-Fact
2015-04-03